What does this research mean for the field?

Nivolumab-induced hypophysitis primarily involves the corticotropic axis and typically improves clinically with corticosteroid treatment, though full hormonal recovery is rare and often necessitates long-term hormone replacement. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Synthesize individual patient-level data to clarify the clinical presentation, management strategies, and outcomes associated with nivolumab-induced hypophysitis.

September 3, 2026BMC Endocrine DisordersOpen Access

Clinical characteristics and management of nivolumab-induced hypophysitis: retrospective analysis based on case reports

View Full Paper

Ask AI

Bookmark

Authors

JHJingjing HuangTongji University SPShan PanShanghai University DZDeshui Zhao

Discussion

Member takes

Implication

Retrospective case review finds frequent adrenal insufficiency and low hormone recovery in nivolumab-induced hypophysitis, highlighting the need for long-term hormone replacement.

Key Points

Synthesize individual patient-level data to clarify the clinical presentation, management strategies, and outcomes associated with nivolumab-induced hypophysitis.
Systematically searched PubMed, EMBASE, Web of Science, WanFang Data, and CNKI through January 31, 2026, for reports on nivolumab-induced pituitary inflammation.
Extracted and synthesized clinical data from 38 case reports and case series encompassing 40 patients (median age 62 years, 72.5% male).
Hypophysitis emerged at a median onset of 20 weeks, presenting primarily with fatigue (82.5%), anorexia/nausea (65.0%), and hyponatremia (42.5%), with abnormal pituitary MRI findings in 46.2%.
Endocrine profiles demonstrated central adrenal insufficiency (median cortisol 2.9 µg/dL, ACTH 38.0 pg/mL) and central hypothyroidism.
All patients received corticosteroids and 92.5% achieved clinical improvement, but full hormonal recovery was uncommon, and nivolumab rechallenge yielded an 18.8% relapse rate.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/6a993643636c6408cfa7f2ea https://doi.org/10.1186/s12902-026-02447-z

View Full Paper

Ask AI

Bookmark

Implication

Retrospective case review finds frequent adrenal insufficiency and low hormone recovery in nivolumab-induced hypophysitis, highlighting the need for long-term hormone replacement.

Clinical characteristics and management of nivolumab-induced hypophysitis: retrospective analysis based on case reports

Discussion

Member takes

Implication

Key Points

Cite This Study

Clinical characteristics and management of nivolumab-induced hypophysitis: retrospective analysis based on case reports

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider